AKZO NOBEL SPONS.ADRS 1/3 (F:AKUP) — Stock Price
AKZO NOBEL SPONS.ADRS 1/3 (F:AKUP) is currently trading at €17.10 EUR, down 8.56% today. Over the past 52 weeks, shares have ranged between €15.40 and €20.80. This page tracks AKZO NOBEL SPONS.ADRS 1/3's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see AKZO NOBEL SPONS.ADRS 1/3 stock valuation.
AKZO NOBEL SPONS.ADRS 1/3 (AKUP) Stock Price Chart — Daily History & Trading Volume
The chart below tracks AKZO NOBEL SPONS.ADRS 1/3's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
AKZO NOBEL SPONS.ADRS 1/3 Income Statement — Revenue, Profit & Earnings by Year
AKZO NOBEL SPONS.ADRS 1/3's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Revenue | €10.16 Billion | €10.71 Billion | €10.67 Billion | €10.85 Billion |
| Cost of Revenue | €6.11 Billion | €6.37 Billion | €6.43 Billion | €6.92 Billion |
| Gross Profit | €4.05 Billion | €4.34 Billion | €4.23 Billion | €3.92 Billion |
| Research & Development | €274.00 Million | €296.00 Million | €270.00 Million | €258.00 Million |
| SG&A | €1.53 Billion | €1.56 Billion | €1.54 Billion | €1.53 Billion |
| Total Operating Expenses | €8.99 Billion | €9.79 Billion | €9.64 Billion | €10.14 Billion |
| Operating Income | €1.16 Billion | €917.00 Million | €1.03 Billion | €708.00 Million |
| EBITDA | — | — | — | — |
| EBIT | — | — | — | — |
| Interest Expense | €211.00 Million | €190.00 Million | €193.00 Million | €106.00 Million |
| Income Before Tax | €998.00 Million | €838.00 Million | €784.00 Million | €602.00 Million |
| Income Tax Expense | — | — | — | — |
| Net Income | €635.00 Million | €542.00 Million | €442.00 Million | €352.00 Million |
AKZO NOBEL SPONS.ADRS 1/3 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes AKZO NOBEL SPONS.ADRS 1/3's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Assets | €13.95 Billion | €14.25 Billion | €14.56 Billion | €14.74 Billion |
| Total Current Assets | €6.06 Billion | €5.84 Billion | €6.04 Billion | €6.24 Billion |
| Cash & Equivalents | — | — | — | — |
| Short-term Investments | €302.00 Million | €165.00 Million | €265.00 Million | €336.00 Million |
| Net Receivables | €1.99 Billion | €2.14 Billion | €2.19 Billion | €2.12 Billion |
| Inventory | €1.53 Billion | €1.72 Billion | €1.65 Billion | €1.84 Billion |
| Property, Plant & Equipment | — | — | — | — |
| Goodwill | €1.39 Billion | €1.44 Billion | €1.43 Billion | €1.38 Billion |
| Total Liabilities | €9.13 Billion | €9.43 Billion | €10.01 Billion | €10.19 Billion |
| Total Current Liabilities | €4.21 Billion | €4.73 Billion | €5.71 Billion | €5.75 Billion |
| Long-term Debt | €3.48 Billion | €3.47 Billion | €2.97 Billion | €3.13 Billion |
| Net Debt | €2.97 Billion | €3.77 Billion | €3.77 Billion | €4.14 Billion |
| Total Stockholder Equity | €4.66 Billion | €4.57 Billion | €4.32 Billion | €4.33 Billion |
| Retained Earnings | €559.00 Million | — | — | — |
AKZO NOBEL SPONS.ADRS 1/3 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how AKZO NOBEL SPONS.ADRS 1/3 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Cash Flow | €915.00 Million | €673.00 Million | €1.13 Billion | €263.00 Million |
| Capital Expenditures | €309.00 Million | €306.00 Million | €286.00 Million | €292.00 Million |
| Free Cash Flow | €606.00 Million | €367.00 Million | €840.00 Million | €-29.00 Million |
| Investing Cash Flow | — | — | — | — |
| Financing Cash Flow | — | — | — | — |
| Dividends Paid | €382.00 Million | €385.00 Million | €368.00 Million | €379.00 Million |
| Stock-Based Compensation | — | — | — | — |
| Depreciation | €378.00 Million | €371.00 Million | €357.00 Million | €368.00 Million |
| Change in Cash | €375.00 Million | €-148.00 Million | €149.00 Million | €300.00 Million |
AKZO NOBEL SPONS.ADRS 1/3 Earnings History — EPS Actual vs. Analyst Estimates
Track AKZO NOBEL SPONS.ADRS 1/3's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Oct 21, 2026 | — | — | — |
| Jul 21, 2026 | — | — | — |
| Apr 22, 2026 | — | — | — |
| Feb 03, 2026 | — | — | — |
| Oct 21, 2025 | — | — | — |
| Jul 21, 2025 | — | — | — |
| Apr 23, 2025 | — | — | — |
| Feb 05, 2025 | — | — | — |